Fundraising Fox

Fosun Pharma

Shanghai Β· 1 people tracked

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Fosun Pharma focuses on innovation-driven pharmaceutical development with emphasis on unmet clinical needs, particularly in oncology, immunology, inflammatory disease, and neurodegenerative conditions. The company is expanding into rare diseases and chronic illness treatment. Core technology platforms include antibody-ADC conjugates, small molecules, and cell therapy, with emerging focus on nuclear medicine and small nucleic acids. The firm operates a global research and development network and aims to accelerate translation of research into clinical solutions.

Source: firm website, verified Aug 6, 2026.

HQ
Shanghai, CN
Instruments
Equity
Founded
1994
Last 12 months
1 investment
Tracked investments
1

Team Β· 1 people

from public directories

What they invest in

from 1 of 1 portfolio companies

Biotech Γ—1Digital Health Γ—1Healthtech Γ—1Medical Devices Γ—1

HQs:United StatesΓ—1

Investments Β· 1 tracked

founders shown can be your intro path
Glycotestglycotest.comJun 2026βœ“ verified

Glycotest develops diagnostic tests for the early detection of liver disease and liver cancer.

BiotechDigital HealthHealthtechMedical DevicesMerion Station, US

Charles Swindell(Executive Officer, Director)

BoardIlian Iliev(Director)inEd Hooper(Director)inJenny Jiang(Director)

Co-investorsEMV Capital

Portfolio news

latest coverage across their companies

Frequently asked questions

What sectors does Fosun Pharma focus on?
Fosun Pharma focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Fosun Pharma located?
Fosun Pharma is headquartered in Shanghai, CN.

Similar investors

Featured in lists